About Jubilant Life Sciences
Jubilant Life Sciences is a company based in Noida (India) founded in 1978 by Hari Bhartia.. The company has 1,055 employees as of March 30, 2024. Jubilant Life Sciences has completed 5 acquisitions, including Bestcro, DRAXIS Health and Hollister-Stier. Jubilant Life Sciences offers products and services including Pharmaceuticals, Drug Discovery Solutions, Proprietary Novel Drugs, and Specialty Chemicals. Jubilant Life Sciences operates in a competitive market with competitors including Akums, Recipharm, Unither, Nectar Lifesciences and CoreRx, among others.
- Headquarter Noida, India
- Employees 1055 as on 30 Mar, 2024
- Founders Hari Bhartia
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Jubilant Pharmova Limited
- Jurisdiction U P, Uttar Pradesh, India
-
Annual Revenue
$759.9 M (USD)2.91as on Mar 31, 2023
-
Net Profit
$-7.8 M (USD)-115.71as on Mar 31, 2023
-
EBITDA
$93.33 M (USD)-32.87as on Mar 31, 2023
-
Latest Funding Round
$86.11 M (USD), Post-IPO
Mar 01, 2010
- Investors
-
Employee Count
1055
as on Mar 30, 2024
-
Investments & Acquisitions
Bestcro
& 4 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Jubilant Life Sciences
Jubilant Life Sciences offers a comprehensive portfolio of products and services, including Pharmaceuticals, Drug Discovery Solutions, Proprietary Novel Drugs, and Specialty Chemicals. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Products for addressing unmet health needs through research and manufacturing.
Services focused on developing innovative drug solutions for global markets.
Specialized drugs created to meet specific health challenges affordably.
Chemicals for nutrition and health applications in various industries.
Funding Insights of Jubilant Life Sciences
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $86.1M
-
First Round
First Round
(01 Jun 2003)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2010 | Amount | Post-IPO - Jubilant Life Sciences | Valuation |
investors |
|
| Jun, 2005 | Amount | Post-IPO - Jubilant Life Sciences | Valuation |
investors |
|
| Jun, 2003 | Amount | Debt – Conventional - Jubilant Life Sciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Jubilant Life Sciences
Jubilant Life Sciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include General Atlantic. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund focused on global markets
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Jubilant Life Sciences
Jubilant Life Sciences has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Bestcro, DRAXIS Health and Hollister-Stier. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Research consulting services are provided for pharmaceutical and biotech sectors.
|
1996 | ||||
|
Radiopharmaceuticals are developed and manufactured for medical imaging applications.
|
1995 | ||||
|
Full-service clinical research organization software and services are provided.
|
1993 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Jubilant Life Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Jubilant Life Sciences Comparisons
Competitors of Jubilant Life Sciences
Jubilant Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Recipharm, Unither, Nectar Lifesciences and CoreRx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| domain | founded_year | HQ Location |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| domain | founded_year | HQ Location |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| domain | founded_year | HQ Location |
CDMO with a focus on early phase drug product development
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Jubilant Life Sciences
Frequently Asked Questions about Jubilant Life Sciences
When was Jubilant Life Sciences founded?
Jubilant Life Sciences was founded in 1978 and raised its 1st funding round 25 years after it was founded.
Where is Jubilant Life Sciences located?
Jubilant Life Sciences is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
How many employees does Jubilant Life Sciences have?
As of Mar 30, 2024, the latest employee count at Jubilant Life Sciences is 1,055.
What is the annual revenue of Jubilant Life Sciences?
Annual revenue of Jubilant Life Sciences is $759.9M as on Mar 31, 2023.
What does Jubilant Life Sciences do?
Founded in 1978, operations are conducted in the pharmaceutical and life sciences sectors from Noida, India. APIs, solid dosage formulations, radiopharmaceuticals, and allergy therapy products are manufactured and supplied, alongside contract services for sterile injectables and drug discovery. Advanced intermediates, fine ingredients, and nutritional products are also produced. Facilities are maintained in India and North America, with products distributed to over 100 countries across North America, Europe, India, and China.
Who are the top competitors of Jubilant Life Sciences?
Jubilant Life Sciences's top competitors include Akums, Nectar Lifesciences and Windlas.
What products or services does Jubilant Life Sciences offer?
Jubilant Life Sciences offers Pharmaceuticals, Drug Discovery Solutions, Proprietary Novel Drugs, and Specialty Chemicals.
How many acquisitions has Jubilant Life Sciences made?
Jubilant Life Sciences has made 5 acquisitions, including Bestcro, DRAXIS Health, and Hollister-Stier.
Who are Jubilant Life Sciences's investors?
Jubilant Life Sciences has 1 investor. Key investors include General Atlantic.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.